International Biotechnology (LON:IBT – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 803.83 and traded as high as GBX 990. International Biotechnology shares last traded at GBX 982, with a volume of 32,813 shares.
International Biotechnology Trading Up 0.4%
The business has a 50-day moving average price of GBX 955.14 and a two-hundred day moving average price of GBX 803.83. The stock has a market capitalization of £314.64 million, a P/E ratio of -299.77 and a beta of 0.21.
International Biotechnology (LON:IBT – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported GBX (11.42) EPS for the quarter. International Biotechnology had a return on equity of 13.67% and a net margin of 90.66%. On average, sell-side analysts forecast that International Biotechnology will post 0.9435943 earnings per share for the current fiscal year.
About International Biotechnology
The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.
The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.
Featured Articles
- Five stocks we like better than International Biotechnology
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
